Deferred Tax Assets, Net of Valuation Allowance of IDEXX LABORATORIES INC /DE from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
IDEXX LABORATORIES INC /DE quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • IDEXX LABORATORIES INC /DE Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $149,760,000, a 39% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $149,760,000 -$96,750,000 -39% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q4 2024 $246,510,000 +$34,823,000 +16% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q4 2023 $211,687,000 +$67,276,000 +47% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $144,411,000 +$21,856,000 +18% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $122,555,000 +$30,000 +0.02% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q4 2020 $122,525,000 +$65,471,000 +115% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q4 2019 $57,054,000 +$2,343,000 +4.3% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q4 2018 $54,711,000 +$5,720,000 +12% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q4 2017 $48,991,000 -$7,748,000 -14% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q4 2016 $56,739,000 31 Dec 2016 10-K 16 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.